Variable
|
Group 1
|
Group 2
|
Group 3
|
F value/χ2
|
η2
|
P Value
|
---|
ASA score
|
1.5 ± 0.5
|
1.5 ± 0.5
|
1.5 ± 0.5
|
0.617
|
0.012
|
0.723
|
1–2
|
51 (85.0%)
|
64 (81.0%)
|
51 (72.9%)
| | | |
3–4
|
9 (15.0%)
|
15 (19.0%)
|
19 (27.1%)
| | | |
BMI
|
27.35 ± 3.64
|
27.19 ± 3.82
|
26.84 ± 3.61
|
0.125
|
0.007
|
0.932
|
Normal (< 25)
|
21 (35.0%)
|
28 (35.5%)
|
26 (37.1%)
| | | |
Overweight (25–30)
|
30 (50.0%)
|
31 (39.2%)
|
30 (42.9%)
| | | |
Obese (> 30)
|
9 (15.0%)
|
20 (25.3%)
|
14 (20.0%)
| | | |
Anesthesia
|
General
|
1 (1.7%)
|
2 (2.5%)
|
10 (14.3%)
| | | |
Spine
|
59 (98.3%%)
|
77 (97.5%)
|
60 (85.7%)
| | | |
Hypertension
|
35 (58.3%)
|
48 (60.7%)
|
57 (81.4%)*
|
8.192
|
/
|
0.036
|
Diabetes
|
18 (30.0%)
|
24 (30.4%)
|
19 (27.1%)
|
0.663
|
/
|
0.792
|
Coronary heart disease
|
14 (23.3%)
|
19 (24.1%)
|
20 (28.5%)
|
0.386
|
/
|
0.697
|
Digestive diseases
|
5 (8.3%)
|
7 (8.8%)
|
7 (10.0%)
|
0.286
|
/
|
0.711
|
Nervous system disease
|
6 (10.0%)
|
9 (11.4%)
|
12 (17.1%)
|
2.861
|
/
|
0.323
|
Immune system disease
|
1 (1.7%)
|
2 (2.5%)
|
0
|
2.102
|
/
|
0.283
|
Respiratory diseases
|
2 (3.3%)
|
3 (3.8%)
|
7 (10.0%)
|
3.287
|
/
|
0.113
|
Peripheral vascular disease
|
1 (1.7%)
|
2 (2.5%)
|
6 (8.5%)
|
1.983
|
/
|
0.204
|
Coagulation abnormalities
|
8 (13.3%)
|
12 (15.2%)
|
11 (15.7%)
|
0.582
|
/
|
0.841
|
- “*” Represent compared with the Group 1and 2, the difference in Group 3 is statistically different